mak 195f
mAbexperimental
Clinical trial activity
0 trials · 0 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Mechanism of action
- TNF-alphaINHIBITOR
TNF inhibitor
Reduces the concentration of interleukin-6 in serum.
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2109177 ↗
- ChEMBLCHEMBL2108887 ↗
Also known as
- afelimomab
- afelimomab
- afelimomab
- afolimomab
- fab 2
- lu-54107
- mak 195f
- mak-195f
- segard
- segard